New oncology strategy: molecular targeting of cancer cells...this article originally appeared in MEDSURG Nursing, 13(3), 191-195 and is reprinted here with permission of the publisher

New understanding of how cancer cells survive, thrive, and metastasize has enabled researchers to create new targeted therapies for cancer treatments, such as melanoma and Kaposi's sarcoma, to minimize the harmful systemic effects of therapy on healthy cells. The specific and selective targets of fu...

Descripción completa

Detalles Bibliográficos
Publicado en:Dermatology Nursing Vol. 17; no. 3; pp. 181 - 187
Autor principal: Capriotti T
Formato: CEU glossary review Journal Article
Publicado: Jannetti Publications, Inc. Jun2005
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106496409&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106496409
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10603441
        38V
      jtl: Dermatology Nursing
      issn: 10603441
      maglogo: N
    pubinfo:
      dt: Jun2005
      vid: 17
      iid: 3
      pid: 4135
      pub: Jannetti Publications, Inc.
      place: Pitman, New Jersey
    artinfo:
      ui:
        106496409
        106496409
        2005118048
        106496409
      ppf: 181
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: New oncology strategy: molecular targeting of cancer cells...this article originally appeared in MEDSURG Nursing, 13(3), 191-195 and is reprinted here with permission of the publisher
      aug:
        au: Capriotti T
        affil: Clinical Assistant Professor, Villanova University, College of Nursing, Villanova, PA
      sug:
        subj:
          Antineoplastic Agents Therapeutic Use
          Cell Physiology Drug Effects
          Growth Substances Antagonists and Inhibitors
          Neoplasms Drug Therapy
          Angiogenesis Inhibitors Therapeutic Use
          Antibodies, Monoclonal Administration and Dosage
          Antibodies, Monoclonal Adverse Effects
          Antibodies, Monoclonal Pharmacodynamics
          Education, Continuing (Credit)
          Molecular Biology
          Oncology Nursing
          Patient Education
          Thalidomide Adverse Effects
          Thalidomide Pharmacodynamics
      ab: New understanding of how cancer cells survive, thrive, and metastasize has enabled researchers to create new targeted therapies for cancer treatments, such as melanoma and Kaposi's sarcoma, to minimize the harmful systemic effects of therapy on healthy cells. The specific and selective targets of future oncology drugs will require a detailed understanding of cancer cell biology, genetics, immunology, and biotechnology.
      pubtype: Academic Journal
      doctype:
        CEU
        glossary
        review
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N